Design and synthesis of (2-(5-chloro-2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)cyclopropyl)methanamine as a selective serotonin 2C agonist This Letter is dedicated to the lasting memory of Harry H. Wasserman, a connoisseur of heterocycles

Tetrahedron Letters

Volumn 56, Issue 23, 2015, Pages 3420-3422

  Cheng, Jianjun ^a   Giguere, Patrick M ^b   Lv, Wei ^a   Roth, Bryan L ^b   Kozikowski, Alan P ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

ALNNHFGNPITCHG UHFFFAOYSA N; InChIKeys SBUGRSZWKNBMEV KOLCDFICSA N

Indexed keywords

CYCLOPROPANE DERIVATIVE; DIHYDROBENZOFURAN DERIVATIVE; METHYLAMINE; SEROTONIN 2C AGONIST; UNCLASSIFIED DRUG; [2 (5 CHLORO 2,2 DIMETHYL 2,3 DIHYDROBENZOFURAN 7 YL)CYCLOPROPYL]METHANAMINE;

ALKYLATION; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG POTENCY; DRUG SCREENING; DRUG SELECTIVITY; DRUG SYNTHESIS;

EID: 84929650088     PISSN: 00404039     EISSN: 18733581     Source Type: Journal    
DOI: 10.1016/j.tetlet.2015.01.060     Document Type: Article

References (18)

1. B.M. Smith, W.J. Thomsen, and A.J. Grottick Expert Opin. Invest. Drugs 15 2006 257
2. M. Berger, J.A. Gray, and B.L. Roth Annu. Rev. Med. 60 2009 355
3. H.Y. Meltzer, and B.L. Roth J. Clin. Invest. 123 2013 4986
4. A. Pazos, D. Hoyer, and J.M. Palacios Eur. J. Pharmacol. 106 1985 539
5. K.A. Berg, W.P. Clarke, K.A. Cunningham, and U. Spampinato Neuropharmacology 55 2008 969
6. D.E. Nichols Pharmacol. Ther. 101 2004 131
7. R.B. Rothman, M.H. Baumann, J.E. Savage, L. Rauser, A. McBride, S.J. Hufeisen, and B.L. Roth Circulation 102 2000 2836
8. X.-P. Huang, V. Setola, P.N. Yadav, J.A. Allen, S.C. Rogan, B.J. Hanson, C. Revankar, M. Robers, C. Doucette, and B.L. Roth Mol. Pharmacol. 76 2009 710
9. A. Mann C.G. Wermuth, Practice of Medicinal Chemistry 2008 Elsevier 363 379
10. Yong.-Jin. Wu Prog. Heterocycl. Chem. 24 2012 1
11. K.M. Dawood Expert Opin. Ther. Pat. 23 2013 1133
12. D.W. Robertson, W.B. Lacefield, W. Bloomquist, W. Pfeifer, R.L. Simon, and M.L. Cohen J. Med. Chem. 35 1992 310
13. M.L. Cohen, W. Bloomquist, J.S. Gidda, and W. Lacefield J. Pharmacol. Exp. Ther. 254 1990 350
14. W.T. Smith, P.D. Londborg, S.L. Blomgren, G.D. Tollefson, and M.E. Sayler J. Clin. Psychopharmacol. 19 1999 125
15. G. Chen, S.J. Cho, X.-P. Huang, N.H. Jensen, A. Svennebring, M.F. Sassano, B.L. Roth, and A.P. Kozikowski ACS Med. Chem. Lett. 2 2011 929
16. M.G. Kadieva, and É.T. Oganesyan Chem. Heterocycl. Compd. 33 1997 1245
17. A.A. Abu-Hashem, H.A.R. Hussein, A.S. Aly, and M.A. Gouda Synth. Commun. 44 2014 2285
18. J.E. Burks Jr., L. Espinosa, E.S. LaBell, J.M. McGill, A.R. Ritter, J.L. Speakman, and M.A. Williams Org. Process Res. Dev. 1 1997 198